Health Catalyst, Inc. (HCAT)
NASDAQ: HCAT · IEX Real-Time Price · USD
7.53
+0.09 (1.21%)
At close: Mar 28, 2024, 4:00 PM
7.39
-0.14 (-1.86%)
After-hours: Mar 28, 2024, 7:21 PM EDT
Health Catalyst Stock Forecast
Stock Price Forecast
The 12 analysts with 12-month price forecasts for Health Catalyst stock have an average target of 12.92, with a low estimate of 8.00 and a high estimate of 16. The average target predicts an increase of 71.58% from the current stock price of 7.53.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for HCAT stock from 13 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
Rating | Oct '23 | Nov '23 | Dec '23 | Jan '24 | Feb '24 | Mar '24 |
---|---|---|---|---|---|---|
Strong Buy | 2 | 2 | 2 | 3 | 3 | 3 |
Buy | 4 | 4 | 5 | 6 | 6 | 7 |
Hold | 4 | 5 | 5 | 3 | 3 | 3 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 10 | 11 | 12 | 12 | 12 | 13 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $16 | Buy | Reiterates | $16 | +112.48% | Mar 5, 2024 |
Keybanc | Keybanc | Buy Maintains $12 → $10 | Buy | Maintains | $12 → $10 | +32.80% | Feb 26, 2024 |
Piper Sandler | Piper Sandler | Buy Reiterates $17 → $15 | Buy | Reiterates | $17 → $15 | +99.20% | Feb 23, 2024 |
Evercore ISI Group | Evercore ISI Group | Buy Maintains $11 → $10 | Buy | Maintains | $11 → $10 | +32.80% | Feb 23, 2024 |
Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $12 → $11 | Strong Buy | Maintains | $12 → $11 | +46.08% | Feb 23, 2024 |
Financial Forecast
Revenue This Year
316.23M
from 295.94M
Increased by 6.86%
Revenue Next Year
352.49M
from 316.23M
Increased by 11.47%
EPS This Year
0.32
from -2.09
EPS Next Year
0.52
from 0.32
Increased by 61.06%
Revenue Forecast
Revenue | 2024 | 2025 | 2026 |
---|---|---|---|
High | 347.6M | 370.7M | 453.6M |
Avg | 316.2M | 352.5M | 409.5M |
Low | 299.9M | 331.0M | 377.3M |
Revenue Growth
Revenue Growth | 2024 | 2025 | 2026 |
---|---|---|---|
High | 17.4% | 17.2% | 28.7% |
Avg | 6.9% | 11.5% | 16.2% |
Low | 1.3% | 4.7% | 7.0% |
EPS Forecast
EPS | 2024 | 2025 | 2026 |
---|---|---|---|
High | 0.47 | 0.68 | 0.96 |
Avg | 0.32 | 0.52 | 0.90 |
Low | -0.01 | 0.34 | 0.83 |
EPS Growth
EPS Growth | 2024 | 2025 | 2026 |
---|---|---|---|
High | - | 113.0% | 85.6% |
Avg | - | 61.1% | 74.2% |
Low | - | 7.1% | 61.4% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.